At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09966 ALPHAMAB-B
Market Closed 09-20 16:08:32
2.660
+0.130
+5.14%
High2.720
Low2.540
Vol4.95M
Open2.540
D1 Closing2.530
Amplitude7.11%
Mkt Cap2.57B
Tradable Cap2.57B
Total Shares964.92M
T/O13.11M
T/O Rate0.51%
Tradable Shares964.92M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Stock Track | ALPHAMAB-B Plunges Despite Positive Clinical Trial Results for Anti-Cancer Drug
Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.